Abstract:Epigenetics has been known to mediate genetic risks and regulate gene expression in complex diseases. Due to substantial epigenetic variation, particularly DNA methylation, is tissue specific, sample accessibility has been one of the major road blockers in epigenetic research for human brain disorders. However, previous studies have shown that DNA methylation can also be significantly regulated by genetics and such effect is relatively consistent cross tissues. A better understanding of this genetic and epigenetic relationship can be very beneficial for the investigation of diseases pathology. In this work, we conducted a comprehensive analysis of genetic influence on DNA methylation across brain and peripheral tissues, characterized genetics and their target CpGs, and their functional relevance to psychiatric diseases. We performed a genome-wide methylation quantitative trait loci (meQTLs) analysis on postmortem brain prefrontal cortex, whole blood and saliva. Cis-acting SNP-methylation pairs (distance < 20k base pairs) were matched across tissues. The overlap of meQTLs and targeted CpG sites in different tissues were evaluated by a Fisher exact test. Cis-effect size among tissues was also compared. While focusing on cross tissue consistent SNP-methylation effects, enrichment tests were applied to explore the genomic distribution of targeted CpG sites, their annotation in functional pathways and diseases, and their enrichment in the CpG set with high brain-blood correspondence. In addition, we tested the enrichment of cross-tissue meQTLs in risk loci of five major psychiatric disorders reported by large-scale genome-wide association studies, and further explored their overlap with cross-tissue expression QTLs. Finally, we constructed cross-tissue consensus co-methylation networks for the meQTL targeted CpG sites. We found significant overlap of meQTLs and targeted CpGs cross tissue (34%-73%). MeQTLs in blood showed the strongest cis-effect followed by brain and saliva regardless of direction of effect. Cross-tissue meQTL targeted CpGs were highly distributed on CpG island shore regions (OR: odds ratio = 1.3, P = 2.8e-99) and had a much higher probability being blood brain correspondent than non-meQTL target CpGs (OR=6.6). Cross-tissue meQTLs showed significant enrichment in risk loci of five major psychiatric disorders (OR: odds ratio = [1.65 - 5.42]). In addition, these cross-tissue meQTLs also enriched significantly in cross-tissue eQTLs (OR = 16.21), where 351 SNPs were meQTl, eQTL, and carried significant schizophrenia risk, mainly from regions 6p21.1 – 6p24.3. Finally, we found more similar co-methylation network structure between brain and blood than brain and saliva, and identified one consensus module showing significant schizophrenia risk (Z= -4.54, p = 5.5e-6). Results show strong cross-tissue similarity of meQTLeffects, especially between brain and blood, and their significant enrichment in psychiatric disorders, supporting the surrogate role of peripheral tissues in studying pathology of genetic effect on brain disorders through methylation.

Identification of SENP7 and UTF1/VENTX as new loci influencing clustered protocadherin methylation across blood and brain using a genome-wide association study

Genome-wide DNA methylation analysis of discordant monozygotic twins reveals consistent sites of differential methylation associated with congenital heart disease

The Interaction Analysis of SNP Variants and DNA Methylation Identifies Novel Methylated Pathogenesis Genes in Congenital Heart Diseases

Variably methylated regions in the newborn epigenome: environmental, genetic and combined influences

Epigenome-wide analysis of DNA methylation and coronary heart disease: a nested case-control study

CHARACTERIZATION OF CROSS-TISSUE Mqtl EFFECTS AND THEIR RELEVANCE IN PSYCHIATRIC DISORDERS

Epigenome-wide Meta-Analysis of Blood DNA Methylation and Its Association with Subcortical Volumes: Findings from the ENIGMA Epigenetics Working Group

: improved discovery of DNA methylation associations with complex traits

Genetic control of individual differences in gene-specific methylation in human brain.

Identification of methylation and hydroxymethylation haplotype blocks as distal regulatory elements aids in deconvolution of heterogeneous brain tissues

Identification of Schizophrenia-Associated Loci by Combining DNA Methylation and Gene Expression Data from Whole Blood

Genome-wide analysis of DNA methylation in 106 schizophrenia family trios in Han Chinese

Genome-wide DNA methylation profiling in blood reveals epigenetic signature of incident acute coronary syndrome

Identification of potential biomarkers for CAD using integration with expression and methylation data and validation by case-control study

Characterization of cross-tissue genetic-epigenetic effects and their patterns in schizophrenia

Integrated DNA methylation and gene expression analysis in the pathogenesis of coronary artery disease

Association of DNA Methylation at CPT1A Locus with Metabolic Syndrome in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study

DNA methylation and general psychopathology in childhood: an epigenome-wide meta-analysis from the PACE consortium

Linking the genetic architecture of cytosine modifications with human complex traits.

Association between DNA methylation and ADHD symptoms from birth to school age: a prospective meta-analysis

Epigenome-wide DNA Methylation Association Study of CHIP Provides Insight into Perturbed Gene Regulation